Biocon Ltd Financial Statement - Biocon Ltd Balance Sheet | Research 360 by Motilal Oswal
16:05 Apr 19

Biocon Ltd.

Sector Pharmaceuticals & Biotechnology Industry Biotechnology
Up
261.65
-5.55 (-2.08%)
Sector Pharmaceuticals & Biotechnology Industry Biotechnology

Biocon Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Biotechnology
Up
261.65
-5.55 (-2.08%)
16:05 Apr 19
Quality
image/svg+xml

59/100
High Financial Strength

Valuation
image/svg+xml

63/100
Affordable Valuation

Technical

53/100
Technically Neutral

Strength

8

Weakness

6

Opportunity

1

Threats

2

2.58 %

ROE %

0.88 %

ROA %

3.87

EPS

187.31

BVPS

4.14 %

Net Profit Margin

Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM 2023
Net Sales
6300.5 7105.8 8184 11174.2 14612.5
Operating Expenses +
4697.4 5453.2 6213.8 8662.5 11232.4
Raw Material
2190.3 2498.6 2975 3817.2 5193.6
Increase Decrease in Cost
-200.8 -290.1 -256.6 -154.1 -396.4
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
1458.8 1741 1880.1 2181 2491.8
Miscellaneous Expenses
1419.9 1640.5 1937.5 4070.6 3943.4
Operating Profit
1603.1 1652.6 1970.2 2511.7 3380.1
Other Income
161.4 254.5 212.7 375.9 971.8
Depreciation
552.2 715.1 814.2 1113.1 1525.5
Interest
64.9 57.7 67.6 419 996.2
Profit before tax and exceptio..
1147.4 1134.3 1301.1 1355.5 1830.2
Exceptional Items
67.5 12.6 -111.1 -291.4 -5.8
PBT
1214.9 1146.9 1190 1064.1 1836
Provision for Taxation
315.1 221.5 211.5 254.1 213.4
Net Profit
870.9 915.7 978.5 810 1611
NET Profit after MI
748.2 740.5 648.4 462.7 1200.2
EPS
6.3 6.19 5.42 3.87 10.04
Operating Profit Margin (%)
25.44 23.26 24.07 22.48 23.13
Net Profit Margin (%)
11.88 10.42 7.92 4.14 8.21

ShareHolding

All Data in Percentage (%)

Mar 24 Dec 23 Sep 23 Jun 23 Mar 23
Promoter 60.60 60.60 60.60 60.60 60.60
FII 5.60 6.60 8.00 9.50 10.20
MF 8.60 9.30 8.30 7.50 7.20
Public 19.70 18.00 16.90 16.80 16.70
Others 5.50 5.50 6.20 5.60 5.30
Shareholder Shares Holding %

Download Our App On: